By Professor Monica M. Lahra

Journal articles

Lahra MM; Kundu R, 2015, 'Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2015', Communicable diseases intelligence quarterly report, 39, pp. E495

Buckley C; Trembizki E; Baird RW; Chen M; Donovan B; Freeman K; Goire N; Guy R; Lahra MM; Regan D; Whiley DM, 2015, 'Multitarget PCR assay for direct detection of penicillinase-producing neisseria gonorrhoeae for enhanced surveillance of gonococcal antimicrobial resistance', Journal of Clinical Microbiology, 53, pp. 2706 - 2708, http://dx.doi.org/10.1128/JCM.00540-15

Hui BB; Ryder N; Su JY; Ward J; Chen MY; Donovan B; Fairley CK; Guy RJ; Lahra MM; Law MG; Whiley DM; Regan DG; Han A, 2015, 'Exploring the benefits of molecular testing for gonorrhoea antibiotic resistance surveillance in remote settings', PLoS ONE, 10, pp. e0133202, http://dx.doi.org/10.1371/journal.pone.0133202

Lahra MM; Enriquez RP, 2015, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2015', Communicable diseases intelligence quarterly report, 39, pp. E297 - E298

Lahra MM, 2015, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2014', Communicable diseases intelligence quarterly report, 39, pp. E294 - E296

Lahra MM; Kundu R, 2015, 'Australian Meningococcal Surveillance Programme quarterly report, 1 January to 31 March 2015', Communicable diseases intelligence quarterly report, 39, pp. E299

Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ, 2015, 'A signal-to-cutoff ratio in the abbott architect HIV Ag/Ab combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting', Journal of Clinical Microbiology, 53, pp. 1709 - 1711, http://dx.doi.org/10.1128/JCM.03583-14

Lahra MM, 2015, 'Australian Gonococcal Surveillance Programme annual report, 2013', Communicable diseases intelligence quarterly report, 39, pp. E137 - E145

Whiley DM; Lahra MM; Unemo M, 2015, 'Prospects of untreatable gonorrhea and ways forward', Future Microbiology, 10, pp. 313 - 316, http://dx.doi.org/10.2217/FMB.14.138

Whiley DM; Lahra MM, 2015, 'Review of 2005 Public Health Laboratory Network Neisseria gonorrhoeae nucleic acid amplification tests guidelines', Communicable diseases intelligence quarterly report, 39, pp. E42 - E45

Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY, 2015, 'Persistence of neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection', Clinical Infectious Diseases, 60, pp. 557 - 563, http://dx.doi.org/10.1093/cid/ciu873

Trembizki E; Doyle C; Buckley C; Jennison A; Smith H; Bates J; Sloots T; Nissen M; Lahra MM; Whiley D, 2015, 'Estimating the prevalence of mixed-type gonococcal infections in Queensland, Australia', Sexual Health, 12, pp. 439 - 444, http://dx.doi.org/10.1071/SH15009

Lahra MM, 2014, 'Australian gonococcal surveillance programme, 1 April to 30 June 2014', Communicable diseases intelligence quarterly report, 38, pp. E390 - E392

Lahra MM; Enriquez RP, 2014, 'Australian Meningococcal Surveillance Programme annual report, 2013', Communicable diseases intelligence quarterly report, 38, pp. E301 - E308

Lahra MM; Enriquez RP, 2014, 'Meningococcal surveillance Australia, 1 July to 30 September 2014', Communicable diseases intelligence quarterly report, 38, pp. E393

Whiley D; Trembizki E; Buckley C; Freeman K; Lawrence A; Limnios A; Pearson J; Smith H; Stevens K; Lahra MM, 2014, 'Penicillinase-Producing Plasmid Types in Neisseria gonorrhoeae Clinical Isolates from Australia', ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 58, pp. 7576 - 7578, http://dx.doi.org/10.1128/AAC.04120-14

Lahra MM; Ryder N; Whiley DM, 2014, 'A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia', New England Journal of Medicine, 371, pp. 1850 - 1851, http://dx.doi.org/10.1056/NEJMc1408109

Stevens K; Zaia A; Tawil S; Bates J; Hicks V; Whiley D; Limnios A; Lahra MM; Howden BP, 2014, 'Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Australia', Journal of Antimicrobial Chemotherapy, 70, pp. 1267 - 1268, http://dx.doi.org/10.1093/jac/dku490

Lahra MM, 2014, 'Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2014', Communicable diseases intelligence quarterly report, 38, pp. E262

Lahra MM, 2014, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2014', Communicable diseases intelligence quarterly report, 38, pp. E159 - E161

Lahra MM, 2014, 'Australian Meningococcal Surveillance Programme quarterly report, 1 January to 31 March 2014', Communicable diseases intelligence quarterly report, 38, pp. E162

Trembizki E; Smith H; Lahra MM; Chen M; Donovan B; Fairley CK; Guy R; Kaldor J; Regan D; Ward J; Nissen MD; Sloots TP; Whiley DM, 2014, 'High-throughput informative single nucleotide polymorphism-based typing of Neisseria gonorrhoeae using the Sequenom MassARRAY iPLEX platform', Journal of Antimicrobial Chemotherapy, 69, pp. 1526 - 1532, http://dx.doi.org/10.1093/jac/dkt544

Lahra MM; Donovan B; Whiley DM, 2014, 'Decreased susceptibility to cephalosporins among gonococci?', The Lancet Infectious Diseases, 14, pp. 186, http://dx.doi.org/10.1016/s1473-3099(14)70015-5

Goire N; Lahra MM; Chen M; Donovan B; Fairley CK; Guy R; Kaldor J; Regan D; Ward J; Nissen MD; Sloots TP; Whiley DM, 2014, 'Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance', Nature Reviews Microbiology, 12, pp. 223 - 229, http://dx.doi.org/10.1038/nrmicro3217

Trembizki E; Doyle C; Jennison A; Smith H; Bates J; Lahra M; Whiley D, 2014, 'A Neisseria gonorrhoeae strain with a meningococcal mtrR sequence', Journal of Medical Microbiology, 63, pp. 1113 - 1115, http://dx.doi.org/10.1099/jmm.0.074286-0

Trembizki E; Buckley C; Lawrence A; Lahra M; Whiley D, 2014, 'Characterization of a novel Neisseria gonorrhoeae penicillinase-producing plasmid isolated in Australia in 2012', Antimicrobial Agents and Chemotherapy, 58, pp. 4984 - 4985, http://dx.doi.org/10.1128/AAC.02993-14

Roberts-Witteveen A; Pennington K; Higgins N; Lang C; Lahra M; Waddell R; Kaldor J, 2014, 'Epidemiology of gonorrhoea notifications in Australia, 2007-12', Sexual Health, 11, pp. 324 - 331, http://dx.doi.org/10.1071/SH13205

Bourne C; Lahra MM; Donovan B, 2014, 'Gaining control of gonorrhoea', Medicine Today, 15, pp. 58 - 60

Trembizki E; Lahra M; Stevens K; Freeman K; Hogan T; Hogg G; Lawrence A; Limnios A; Pearson J; Smith H; Nissen M; Sloots T; Whiley DM, 2013, 'A national quality assurance survey of Neisseria gonorrhoeae testing', Journal of Medical Microbiology, 63, pp. 45 - 49, http://dx.doi.org/10.1099/jmm.0.065094-0

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2013', Communicable diseases intelligence quarterly report, 37, pp. E436 - E437

Lahra MM; Enriquez R, 2013, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2013', Communicable diseases intelligence quarterly report, 37, pp. E438

Lahra MM; Lo YR; Whiley DM, 2013, 'Gonococcal antimicrobial resistance in the Western Pacific Region', Sexually Transmitted Infections, 89, http://dx.doi.org/10.1136/sextrans-2012-050906

Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM, 2013, 'One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia', Sexual Health, 10, pp. 460 - 462, http://dx.doi.org/10.1071/SH13077

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme annual report, 2012', Communicable diseases intelligence quarterly report, 37, pp. E233 - E239

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2013', Communicable diseases intelligence quarterly report, 37, pp. E280 - E281

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2013', Communicable diseases intelligence quarterly report, 37, pp. E278 - E279

Lahra MM; Enriquez RP, 2013, 'Australian Meningococcal Surveillance Programme annual report, 2012', Communicable diseases intelligence quarterly report, 37, pp. E224 - E232

Lahra MM; Enriquez R, 2013, 'Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2013', Communicable diseases intelligence quarterly report, 37, pp. E282

Esterman EE; Lahra MM; Zurynski YA; Booy R; Elliott EJ, 2013, 'Influenza infection in infants aged <6 months during the H1N1-09 pandemic: A hospital-based case series', Journal of Paediatrics and Child Health, 49, pp. 635 - 640, http://dx.doi.org/10.1111/jpc.12266

Tabrizi SN; Unemo M; Golparian D; Twin J; Limnios AE; Lahra M; Guy R, 2013, 'ANALYTICAL EVALUATION OF THE GENEXPERT (R) CT/NG, THE FIRST GENETIC POINT OF CARE ASSAY FOR SIMULTANEOUS DETECTION OF NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS', SEXUALLY TRANSMITTED INFECTIONS, 89, pp. A360 - A360, http://dx.doi.org/10.1136/sextrans-2013-051184.1125

Lusk MJ; Uddin RNN; Lahra MM; Garden FL; Kundu RL; Konecny P, 2013, 'Pharyngeal Gonorrhoea in Women: An Important Reservoir for Increasing Neisseria gonorrhoea Prevalence in Urban Australian Heterosexuals?', Journal of Sexually Transmitted Diseases, 2013, pp. 967471, http://dx.doi.org/10.1155/2013/967471

Lahra MM; Enriquez R, 2013, 'Meningococcal Surveillance Australia reporting period 1 January to 31 March 2013', Communicable diseases intelligence quarterly report, 37, pp. E179

Goire N; Lahra MM; Ohnishi M; Hogan T; Liminios AE; Nissen MD; Sloots TP; Whiley DM, 2013, 'Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain', EUROSURVEILLANCE, 18, pp. 18 - 23, http://dx.doi.org/10.2807/1560-7917.ES2013.18.14.20444

Whiley DM; Goire N; Rahimi F; Lahra MM; Limnios AE; Nissen MD; Sloots TP, 2013, 'Real-time PCR genotyping of Neisseria gonorrhoeae isolates using 14 informative single nucleotide polymorphisms on gonococcal housekeeping genes', Journal of Antimicrobial Chemotherapy, 68, pp. 322 - 328, http://dx.doi.org/10.1093/jac/dks381

Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G, 2013, 'Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.', The Journal of antimicrobial chemotherapy, 68, pp. 1445 - 1447, http://dx.doi.org/10.1093/jac/dkt017

Lahra MM, 2013, 'Gonococcal surveillance Australia: quarter 3, 2012.', Communicable diseases intelligence quarterly report, 37

Goire N; Lahra MM; Ohnishi M; Hogan T; Liminios AE; Nissen MD; Sloots TP; Whiley DM, 2013, 'Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain', Eurosurveillance, 18, http://dx.doi.org/10.2807/1560-7917.ES2013.18.14.20444

Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM, 2012, 'The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance', Sexual Health, 9, pp. 422 - 429, http://dx.doi.org/10.1071/SH12026

Saab J; Bell SM; Lahra MM, 2012, 'Vaginal carriage rate of streptococcal pyogenes in 1600 pregnant women', PATHOLOGY, 44, pp. 567 - 568, http://dx.doi.org/10.1097/PAT.0b013e3283582983

Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW, 2012, 'In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: Ertapenem for treatment of gonorrhea?', Antimicrobial Agents and Chemotherapy, 56, pp. 3603 - 3609, http://dx.doi.org/10.1128/AAC.00326-12

Back to profile page